Doctor profile · Federal record
Dr. Saba Ali, M.D.
Dermatology Physician (CMS: Dermatology) · Dermatopathology Physician · Pittsburgh, PA
- NPI 1861689283
- Accepts Medicare
- MIPS 94.6 / 100 · 2023
- 19 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5001 Centre Ave Fl 3
Pittsburgh, PA 152131807
(800) 845-3573
Credentials & registration
- NPI registered
- September 2007 — 19 yrs on file
- Profile last updated
- January 7, 2014
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Ohio #35099853
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1861689283. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,019
Distinct HCPCS
10
Medicare allowed
$59,318
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 337 | 64 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 293 | 258 | $87 | |
17000 |
Destruction of precancer skin growth, 1 growth | 111 | 98 | $50 | |
11102 |
Biopsy of related skin growth, first growth | 97 | 92 | $89 | |
17110 |
Destruction of skin growth, 1-14 growths | 64 | 62 | $105 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 38 | 35 | $123 | |
11103 |
Biopsy of related skin growth, each additional growth | 25 | 19 | $48 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 24 | 24 | $109 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 16 | 15 | $55 | |
17261 |
Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 14 | 12 | $117 |
In context: peer comparison
Among 18 peers in Pittsburgh Dermatology Physician, average services per provider: 113. This provider delivers 9.0× the peer median.Open Payments
Industry payments received
All-time total
$1,144
Transactions
59
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Pfizer INC. | 10 | $237.94 | |
| Janssen Biotech, INC. | 16 | $222.23 | |
| Lilly USA, LLC | 6 | $102.25 | |
| Abbvie INC. | 5 | $94.08 | |
| Amgen INC. | 4 | $85.71 | |
| Novartis Pharmaceuticals Corporation | 3 | $73.84 | |
| Fresenius Kabi USA, LLC | 3 | $50.56 | |
| Regeneron Healthcare Solutions, INC. | 2 | $48.01 | |
| Dermavant Sciences, INC. | 2 | $41.37 | |
| Sun Pharmaceutical Industries INC. | 2 | $36.51 | |
| Biofrontera INC. | 2 | $31.62 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $27.16 | |
| Genzyme Corporation | 1 | $22.35 | |
| Incyte Corporation | 1 | $20.38 | |
| Arcutis Biotherapeutics, INC. | 1 | $16.67 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
501
Patients
279
Total drug cost
$16,771
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 122 | 71 | $3,187 |
| Triamcinolone Acetonide | Generic | 81 | 61 | $816 |
| Clobetasol Propionate | Generic | 60 | 40 | $4,330 |
| Mometasone Furoate | Generic | 31 | 19 | $862 |
| Metronidazole | Generic | 29 | 16 | $1,916 |
| Clindamycin Phosphate | Generic | 28 | 11 | $1,111 |
| Mupirocin | Generic | 21 | 19 | $177 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 19 | 12 | $519 |
| Betamethasone Dipropionate | Generic | 18 | 15 | $799 |
| Desonide | Generic | 18 | 15 | $1,212 |
Frequently asked questions
What is Dr. Saba Ali's medical specialty?
Dr. Saba Ali practices Dermatology Physician in Pittsburgh, PA.
Where does Dr. Saba Ali practice?
Dr. Saba Ali practices at 5001 Centre Ave Fl 3, Pittsburgh, PA 152131807. Office phone: 8008453573.
What is Dr. Saba Ali's NPI?
Dr. Saba Ali's National Provider Identifier (NPI) is 1861689283, issued by NPPES.
Does Dr. Saba Ali accept Medicare assignment?
Yes. Dr. Saba Ali accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Saba Ali commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.